Research is being conducted on the evolution of biopsy methods for non-small cell lung cancer (NSCLC), including the use of liquid biopsies and targeted biopsy approaches. Studies are exploring how lung cancer metastases evolve over time and how this information can be used to improve diagnosis and treatment. The field appears to be shifting towards more precise and personalized approaches to understanding and addressing tumor evolution and heterogeneity.